Effectiveness of Secretome from Human Umbilical Cord Mesenchymal Stem Cells in Gel (10% SM-hUCMSC Gel) for Chronic Wounds (Diabetic and Trophic Ulcer) – Phase 2 Clinical Trial
DOI: https://doi.org/10.2147/JMDH.S408162
2023-06-23
Journal of Multidisciplinary Healthcare
Abstract:Sukmawati Tansil Tan, 1 Putri Bennya Aisyah, 2 Yohanes Firmansyah, 2 Nathasia Nathasia, 2 Erwin Budi, 2 Siufui Hendrawan 3, 4 1 Department of Dermatology and Venereology, Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia; 2 Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia; 3 Department of Biochemistry and Molecular Biology, Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia; 4 Tarumanagara Human Cell Technology Laboratory, Tarumanagara University, Jakarta, Indonesia Correspondence: Siufui Hendrawan, Email Background: Chronic wounds carry financial burdens and increase morbidity and mortality, especially in diabetic ulcers and Hansen's Morbus. More than 50% of chronic ulcers are difficult to heal with regular treatment and require new types of therapy such as the use of secretome of human umbilical cord mesenchymal stem cells (SM-hUCMSC). Methods: This experimental study was carried out to see the effectiveness of using SM-hUCMSC in diabetic ulcers and Hansen's Morbus in four medical facilities (multicentre). The level of active secretion has been measured by default in 10% SM-hUCMSC gel, used as a treatment intervention. The primary outcome is wound healing in terms of the length, width, and extent of the wound. The secondary is the side effects of treatment 2 weeks after administration. Follow-up visits will be scheduled at 1 and 2 weeks post-treatment. Results: Forty-one chronic ulcers successfully followed the study until the end. In patients with chronic ulcers, the mean ulcer length, width, and area were 1.60 (0,50– 13,0), 1.3 (0,5– 6,0), and 2.21 (0,25– 78) cm square, respectively, before interventions and 1 (0– 12), 0,8 (0– 6,0), and 1 (0– 72) square cm after interventions at the second follow-up. The change between the beginning and end of the intervention was significant (p-value < 0.05). Conclusion: The use of 10% SM-hUCMSC gel topically has been proven effective in accelerating the process of wound healing, especially chronic ulcers with side effects that are not present in this study. Keywords: chronic wound healing, secretome of human umbilical cord-derived MSCs gel, diabetic chronic ulcers, leprosy Chronic wound is defined as a wound that is difficult to heal according to the natural healing process with longer healing time to produce functional and anatomical integrity, usually more than 3 months, or a wound that has undergone a healing process but is imperfect in terms of anatomy and functional. 1 The terminology of chronic wounds is often referred to as ulcer wounds that are difficult to heal and usually persist in 4 weeks or more. 2 Chronic wounds are divided into four main groups based on the etiology of the cause, venous ulcers, diabetic ulcers, namely arterial insufficiency ulcers, and pressure ulcers. 3 The prevalence of chronic wounds in developed countries is 1% to 2% of the total population. 4 The prevalence of chronic wounds will often increase with increasing age and the presence of comorbidities that inhibit the wound healing process. 5 The most severe complication of chronic ulcers is the occurrence of persistent infections, such as gangrene, infective venous eczema, cellulitis, bleeding, and amputation of the lower limb. 6 A clinician has to work hard to take care of and handle patients with long-term injuries. Clinicians have to deal with the fact that there are not many wound care techniques that have been proven to work and that chronic ulcers do not heal very often. A special study from Germany says that each year, more than 4.5 million people are treated for long-term injuries that cost up to 5 billion Euros to care for. 7 The extremely low rate of wound healing in chronic wounds 6 has a substantial impact on the health and quality of life of patients and their family. Social isolation, shame, anxiety, difficulties, sadness, loss of function and movement, pain, the financial burden of hospitalization, complications of sickness, and even death are some of the consequences. 8 Previous research has demonstrated that persistent ulcers are a considerable burden and frequently result in a very low quality of life for their victims. In order to improve the quality of life of persons with chronic ulcers, it is vital to provide wound care and ulcer management that are both efficient and cost-effective. 9 The two most common types of chronic wounds encountered in developing areas are diabetic ulcers and trophic ulcers. The most common chronic ulcer is ulcers due to diabetes mellitus or often referred to as diabetic foot ulcers, with an annual -Abstract Truncated-
health care sciences & services